Specific protein degradation is being explored as a substitute approach in cancer, whereby the natural protein degradation program is co-opted for therapeutic uses. Not long ago created novel molecules named proteolysis-focusing on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One particular ligand binds to your https://www.directivepublications.org/journal-of-clinical-breast-cancer/